By performing a more thorough investigation of the TCGA and other independent LIHC cohorts in this study, we clarify the context of the deregulation of NAA40 in LIHC and its prognostic role in aggressive tumours with P53 mutations. This evidence concerns the gene NAA40 and neoplasm.